advertisement

---

ChemMedChem 13

Showing records 1 to 13 | Display all abstracts in ChemMedChem

126743 Discovery of Novel 2-Oxindoles as Compounds with Antiglaucoma Activity
Eremeev RO
ChemMedChem 2025; 20: e202400977

---

126650 Advances in Lipid Nanoparticle-Based Disease Treatment
Zhou Y
ChemMedChem 2025; 20: e202400938

---

126743 Discovery of Novel 2-Oxindoles as Compounds with Antiglaucoma Activity
Efremov AM
ChemMedChem 2025; 20: e202400977

---

126650 Advances in Lipid Nanoparticle-Based Disease Treatment
Ge Q; Wang X
ChemMedChem 2025; 20: e202400938

---

126743 Discovery of Novel 2-Oxindoles as Compounds with Antiglaucoma Activity
Zakharova DV
ChemMedChem 2025; 20: e202400977

---

126650 Advances in Lipid Nanoparticle-Based Disease Treatment
Wang Y
ChemMedChem 2025; 20: e202400938

---

126743 Discovery of Novel 2-Oxindoles as Compounds with Antiglaucoma Activity
Beznos OV; Sokolova EV
ChemMedChem 2025; 20: e202400977

---

126650 Advances in Lipid Nanoparticle-Based Disease Treatment
Sun Q; Wang J
ChemMedChem 2025; 20: e202400938

---

126743 Discovery of Novel 2-Oxindoles as Compounds with Antiglaucoma Activity
Kalitin KY
ChemMedChem 2025; 20: e202400977

---

126650 Advances in Lipid Nanoparticle-Based Disease Treatment
Yang T
ChemMedChem 2025; 20: e202400938

---

126743 Discovery of Novel 2-Oxindoles as Compounds with Antiglaucoma Activity
Mukha OY; Vinogradova DV
ChemMedChem 2025; 20: e202400977

---

126650 Advances in Lipid Nanoparticle-Based Disease Treatment
Wang C
ChemMedChem 2025; 20: e202400938

---

126743 Discovery of Novel 2-Oxindoles as Compounds with Antiglaucoma Activity
Veselov IM; Shevtsov PN; Dubova LG; Babkov DA; Spasov AA; Shevtsova EF; Lozinskaya NA
ChemMedChem 2025; 20: e202400977

---